# Abbott Laboratories (ABT) — Q3-2021 Earnings Results

**Report date:** 2021-10-20 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q3-2021

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Up 3.33%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.40 | N/A | +51.84% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Abbott Laboratories reported a strong earnings per share figure that exceeded expectations significantly, leading to a positive stock reaction of 3.33%. However, there was no revenue data provided, which leaves some uncertainty about overall performance. Investors may view the EPS beat as a sign of operational strength, but the lack of additional context from management could lead to cautious sentiment moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q3-2021_